Barry Manilow is recovering after catching a "cancerous spot" on his lung early. The 82-year-old singer revealed on Instagram that a lengthy bout with bronchitis led to the discovery of the cancer ...

The “Mandy” and “Copacabana” singer said he would undergo surgery to remove a cancerous spot on his left lung, and he postponed several concert dates. By Derrick Bryson Taylor The singer Barry Manilow ...

Barry Manilow has revealed that he has been diagnosed with lung cancer. The singer shared a statement on Instagram revealing his diagnosis and that he needs to reschedule his January shows in order to ...

Global music superstar Barry Manilow has been diagnosed with lung cancer and has postponed arena tour dates originally scheduled for January. The “Copacabana” and “Mandy” singer-songwriter revealed ...

Barry Manilow has revealed he’s been diagnosed with lung cancer. The music legend, 82, explained that the diagnosis came after a long stretch of what doctors thought was bronchitis. “As many of you ...

Barry Manilow told fans he has cancer in a statement expressing optimism about his prognosis. “As many of you know I recently went through six weeks of bronchitis followed by a relapse of another five ...

Barry Manilow has announced that he was diagnosed with lung cancer. “We just finished five great Christmas concerts at the McCallum Theatre in Palm Desert,” Manilow, 82, began a statement shared via ...

Barry Manilow has been diagnosed with lung cancer. The 82-year-old singer shared the health news on Instagram on Monday. “As many of you know, I recently went through six weeks of bronchitis followed ...

Barry Manilow has been diagnosed with lung cancer and will be postponing his January concerts. “I’m very sorry that you have to change your plans,” the “Mandy” singer wrote in a statement posted to ...

Barry Manilow took to Instagram on Monday to reveal he’s been recently diagnosed with lung cancer. The singer/ songwriter said that he battled bronchitis for six weeks, only for it to return for ...

Phase III trial involved 594 patients across 20 countries Ceralasertib-Imfinzi combo showed no new safety concerns AstraZeneca shares fall 1% after trial results Dec 22 (Reuters) - AstraZeneca (AZN.L) ...